On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE:ABT) as her final trade.

On Monday, Raymond James maintained Abbott Laboratories with an Outperform and lowered the price target from $123 to $116, while BTIG maintained the stock with a Buy and raised the price target from $125 to $130.

Benzinga's analyst rating data finds a consensus Buy rating on ABT.

Jenny Harrington of Gilman Hill Asset Management said National Retail Properties, Inc. (NYSE:NNN) has a 5% dividend yield.

The company’s Board of Directors recently declared a quarterly dividend of 55 cents per share.

Don’t forget to check out our premarket coverage here

Stephen Weiss of Short Hills Capital Partners named UnitedHealth Group Incorporated (NYSE:UNH), which reported better-than-expected Q1 results and increased 2023 guidance.

Joseph Terranova of Virtus Investment Partners picked JPMorgan Chase & Co. (NYSE:JPM), which reported stronger-than-expected results for its first quarter, on Friday.

Price Action: Abbott Laboratories shares rose 0.5% to close at $104.52, while National Retail Properties gained 2% to settle at $43.40 on Monday. UnitedHealth fell 1.3% to $505.35, while JPMorgan rose 0.8% to $139.83 on Monday.

Check This Out: Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter